Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04087174
Title A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site Indianapolis Indiana 46202 United States Details
Research Site Omaha Nebraska 68114 United States Details
Research Site White Plains New York 10601 United States Details
Research Site Gettysburg Pennsylvania 17325 United States Details
Research Site Myrtle Beach South Carolina 29572 United States Details
Research Site Barcelona 08036 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field